Dual-engine ferroptosis initiation via a hypoxia-responsive nanoplatform for colorectal cancer immunotherapy

Authors:
  • CCChengyuan Cai
    Chengyuan Cai
  • XCXuming Chen
    Xuming Chen
  • HHHonglei Hu
    Honglei Hu
  • ZQZeyang Qiu
    Zeyang Qiu
  • YCYuanhao Chen
    Yuanhao Chen
  • JCJun Chen
    Jun Chen
  • PHPei Huang
    Pei Huang
  • JWJiaxiang Wu
    Jiaxiang Wu
  • ZDZhiwei Duan
    Zhiwei Duan

Abstract
Despite the promise of immunotherapy for colorectal cancer (CRC), efficacy is limited by an immunosuppressive microenvironment that resists single-modality interventions. Herein, we propose a dual‑engine ignition strategy for ferroptosis using a hypoxia‑responsive gadolinium‑coordination nanoplatform (PAD@CR) prepared via a one‑pot reaction among Gd³⁺, chlorin e6 (Ce6), retinoic acid (RA), and hypoxia‑sensitive PEG. This platform integrates two coordinated engines in a single system: Ce6 serves as the oxidative engine, generating ROS upon ultrasound activation, while RA acts as the brake‑release engine, inhibiting glycolysis to deplete NADPH and GSH, thereby dismantling the antioxidant defense. The convergence of these two orthogonal inputs overwhelms redox homeostasis and triggers immunogenic ferroptosis. The resulting DAMPs establish a positive feedback loop with α‑PD‑L1 therapy, promoting CD8⁺ T cell infiltration and long‑term immunological memory. Notably, IFN‑γ from activated T cells further suppresses GPX4, amplifying ferroptosis in a closed‑loop manner. In vivo, this dual‑engine ignition significantly inhibits tumor growth and extends survival without systemic toxicity. With scalable synthesis, integrated imaging‑therapy functions, and the ability to convert "cold" tumors into "hot" lesions, this nanoplatform offers a translatable strategy to overcome immunotherapy resistance in CRC.